Search Results
Viewing: 101-110 of 147 | All
News
Jerry Mendell, MD, Announced as King Faisal Prize Laureate in Medicine
Jerry Mendell, MD, senior advisor in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital, is this year’s recipient of the King Faisal Prize for Medicine for his contributions toward the screening, diagnosis and treatment of neuromuscular diseases, including spinal muscular atrophy (SMA), Duchenne muscular dystrophy (DMD) and limb girdle muscular dystrophy.
Article
Awards and Recognition
A sampling of the many comments from patients and families - “I will recommend our doctor to everyone who may need. She encouraged us to ask questions, and she described everything in detail. This was the best staff and experience we could've asked for. I have never experienced such great care all around from a facility. Everyone seemed to love their job and enjoy being there even for how early in the morning it was. Thank you, Nationwide Children’s, for the best experience and the best care for my baby.”
Condition
Dandy-Walker Syndrome
Dandy-Walker Syndrome (DWS) is a congenital condition where the cerebellum does not develop normally. The cerebellum is an area at the back of the brain that controls movement and balance. With DWS, parts of the cerebellum may never develop, may be very small, or may become filled with fluid.
News
Cure Duchenne to Host a Webinar on Duplication Research for Duchenne Muscular Dystrophy with Dr. Kevin Flanigan from Nationwide Childrens Hospital on April 6
NEWPORT BEACH, Calif. -- CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, will host an “Update on Duplication Mutation Research for Duchenne Muscular Dystrophy” webinar with Dr.
News
How a Network of Hospitals Reduced Average Age at Cerebral Palsy Diagnosis to 9.5 Months
Five hospital systems in the United States have become the first in the world to successfully implement, in clinical practice, international CP diagnosis guidelines that were released in 2017. Their efforts, which resulted in an average decrease of 10 months in time-to-diagnosis, demonstrate the practicality and effectiveness of the guidelines for improving age at diagnosis — a key requirement for early interventions, which can improve CP-related developmental outcomes substantially
News
First U.S. Trial of DMD Gene Therapy
EMBARGOED FOR RELEASE: 6:00 a.m. Wednesday, March 29, 2006Contacts: Bob Mackle Pam Barber Jade Samulski Director of Public Information Director of Media Relations and Support Services Director of Program Management Muscular Dystrophy Association Columbus Childrens Hospital Asklepios
News
4-Year Study Finds No Correlation Between Head Impacts and Cognitive Outcomes in Youth Tackle Football Players
Dr. Sean Rose and colleagues collaborated with MORE Foundation, the Complex Concussion Clinic at Nationwide Children's, and other researchers to prospectively follow youth tackle football players in real time across four seasons, which can account for confounding factors. The study, recently published in JAMA Network Open, was conducted from July 2016 through January 2020, and enrolled players from four football teams. A total of 70 male players, 9-12 years of age, who were in 5th and 6th grade, volunteered to participate, with 18 completing all four years of the study.
News
Nationwide Children’s Hospital Dedicates Abigail Wexner Research Institute at Nationwide Children’s Hospital
Nationwide Children’s Hospital dedicated the hospital’s Research Institute as the Abigail Wexner Research Institute at Nationwide Children’s Hospital. This naming recognizes Mrs. Wexner, whose ongoing, passionate advocacy has ushered in a period of unprecedented transformation at the hospital.
Specialty
Cardiac Neurodevelopmental Outcomes Program
The Heart Center’s Cardiac Neurodevelopmental Outcomes Program (CNOP) evaluates children with congenital heart disease who are at a higher risk for developmental delays or concerns and helps them reach their full potential.
Condition
Intracranial Hypertension (Pseudotumor Cerebri)
Idiopathic intracranial hypertension, sometimes called pseudotumor cerebri, is a condition in which the cerebro-spinal fluid is not able to drain normally.